Wizemann, Theresa M <br/><br/>
Breakthrough business models : drug development for rare and neglected diseases and individualized therapies : workshop summary 
Theresa Wizemann, Sally Robinson, and Robert Giffin ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies 
 - Washington, DC  National Academies Press  2009 
 - xviii, 131 p. : ill. ; 23 cm 
<br/><br/> Includes bibliographical references (p. 104-105) 
<br/><br/><label>ISBN: </label>9780309120883 
<br/><br/><label>ISSN: </label>2010478547 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Drugs - Design<br/>Models, Economic - United States<br/>Orphan Drug Production - economics - United States<br/>Orphan drugs - Government policy - United States<br/>Pharmaceutical policy - United States<br/>Research - economics - United States
<br/><br/><label>Dewey Class. No.: </label>615.19 WIZ